Levofloxacin plus Metronidazole Administered Once Daily versus Moxifloxacin Monotherapy against a Mixed Infection of Escherichia coli and Bacteroides fragilis in an In Vitro Pharmacodynamic Model

Moxifloxacin has been suggested as an option for monotherapy of intra-abdominal infections. Recent data support the use of a once-daily metronidazole regimen. The purpose of this study was to investigate the activity of levofloxacin (750 mg every 24 h [q24h]) plus metronidazole (1,500 mg q24h) compa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hermsen, Elizabeth D., Hovde, Laurie B., Sprandel, Kelly A., Rodvold, Keith A., Rotschafer, John C.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2005
Assuntos:
Experimental Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC547281/
https://ncbi.nlm.nih.gov/pubmed/15673752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.2.685-689.2005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares